The First Randomized Trial Comparing Two Patient-driven Approaches to Initiate and Titrate Prandial Insulin Lispro in Type 2 Diabetes In this Homerun Slides series, courtesy of Dr. Steven Edelman, on the AUTONOMY Trial we get an inside look at the groundbreaking results and conclusions that can be drawn from the patient driven ...

Steve Freed introduces Dr. Edelman who tells us about the Taking Control of Your Diabetes (TCOYD) programs which began in 1985 and now are up to 12 conventions a year, a TV show, a website, and a book, helping to bring diabetes education to millions of diabetes patients each year. More videos ...

Dr. Steven V. Edelman discusses the results of a study he and his team did with patients to see how their perception of their blood sugars varied from their actual results. The results, he says, reinforce the idea of “Test, Don’t Guess.” Many patients said they could “feel” what their blood sugar was ...

Dr. Edelman talks about how he believes that the diabetes doctor visit has to be redefined because the current way we interview patients is very inefficient. So he starts off each initial visit by asking the patient if they have any questions for him. This way the questions don’t get ...

Dr. Edelman talks about the new healthcare and how Shared Medical Appointments (SMA’s) can make a huge difference in the efficiency of practices and the well-being of a patients. He has just received permission to begin using SMA’s in his own practice and has already set-up two groups, one for ...

Dr. Edelman gives us an update on the TCOYD programs for 2012-2012 including; the fact that they are getting bigger each year with about 1500 people at each convention now; the type 1 track will be starting much earlier in the day this year with more special sessions; and the TCOYD ...

Dr. Edelman gives us his thoughts on how the GLP-1 analogs have changed the way we practice, and why he thinks the GLP-1 drugs are the single most important advance for type 2 patients in recent years. He says that GLP-1’s are not being prescribed as much as they should be probably ...

Long-Term Complications and Treatments Steve V. Edelman, MD Robert R. Henry, MD Microvascular Complications (cont’d) Gastroparesis This neuropathy should be suspected in patients with nausea, vomiting, early satiety, abdominal distention, and bloating following a meal, and is secondary to delayed emptying and retention of gastric contents. The delay in gastric emptying ...

Long-Term Complications and Treatments Steve V. Edelman, MD Robert R. Henry, MD Microvascular Complications (cont’d) Treatment for Diabetic Nephropathy Treatment is aimed at early detection and prevention, focusing specifically on improving glycemic control, aggressively treating hypertension (e.g., with ACE inhibitor or ARB therapy and other agents as necessary), and restricting ...

Long-Term Complications and Treatments Steve V. Edelman, MD Robert R. Henry, MD Microvascular Complications Retinopathy, nephropathy, and neuropathy are the major microvascular complications of Type 2 diabetes. Prevention, early detection, and aggressive treatment are essential to reduce associated morbidity and mortality. Good metabolic control has been clearly shown to prevent the ...